Abstract:Objective: Cure models are frequently used in survival analysis to account for a cured fraction in the data. When there is a cure rate present, researchers often prefer cure models over parametric models to analyse the survival data. These models enable the ability to define the probability distribution of survival durations for patients who are at risk. Various distributions can be considered for the survival times, such as Exponentiated Weibull Exponential (EWE), Exponential Exponential (EE), Weibull and lognormal distribution. The objective of this research is to choose the most appropriate distribution that accurately represents the survival times of patients who have not been cured. This will be accomplished by comparing various non-mixture cure models that are based on the EWE distribution with its sub-distributions, and distributions distinct from those belonging to the EWE distribution family. Material and methods: A sample of 85 patients diagnosed with superficial bladder tumours was selected to be used in fitting the non-mixture cure model. In order to estimate the parameters of the suggested model, which takes into account the presence of a cure rate, censored data, and covariates, we utilized the maximum likelihood estimation technique using R software version 3.5.7. Result: Upon conducting a comparison of various parametric models fitted to the data, both with and without considering the cure fraction and without incorporating any predictors, the EE distribution yields the lowest AIC, BIC, and HQIC values among all the distributions considered in this study, (1191.921/1198.502, 1201.692/1203.387, 1195.851/1200.467). Furthermore, when considering a non-mixture cure model utilizing the EE distribution along with covariates, an estimated ratio was obtained between the probabilities of being cured for placebo and thiotepa groups (and its 95% confidence intervals) were 0.76130 (0.13914, 6.81863). Conclusion: The findings of this study indicate that EE distribution is the optimal selection for determining the duration of survival in individuals diagnosed with bladder cancer.

Objective Bayesian Analysis of Weibull Mixture Cure Model

A Bayesian semiparametric accelerate failure time mixture cure model

A Weibull Mixture Cure Frailty Model for High-dimensional Covariates

Semiparametric Estimation for Proportional Hazards Mixture Cure Model Allowing Non-Curable Competing Risk

Approximate Bayesian inference for mixture cure models

Modeling clustered long-term survivors using marginal mixture cure model.

Smooth Semi‐nonparametric Analysis for Mixture Cure Models and Its Application to Breast Cancer

Bayesian inference and cure rate modeling for event history data

A Support Vector Machine Based Cure Rate Model For Interval Censored Data

Partly linear single-index cure models with a nonparametric incidence link function

Objective Bayesian analysis for bivariate Marshall–Olkin exponential distribution

Semiparametric Estimation for Accelerated Failure Time Mixture Cure Model Allowing Non-Curable Competing Risk

A 2-step estimation procedure for semiparametric mixture cure models

Non-Mixture Cure Model Estimation in Bladder Cancer Patients: A Novel Approach with Exponentiated Weibull Exponential Distribution

A New Mixture Model With Cure Rate Applied to Breast Cancer Data

Bayesian joint analysis of heterogeneous- and skewed-longitudinal data and a binary outcome, with application to AIDS clinical studies

Objective Bayesian analysis for Weibull distribution with application to random censorship model

Accelerated hazards mixture cure model

A semiparametric accelerated failure time-based mixture cure tree

Maximum likelihood estimation of semiparametric mixture component models for competing risks data

An Alternative Estimation Method for the Semiparametric Accelerated Failure Time Mixture Cure Model